Maintenance Therapy with FOLFIRI after FOLFIRINOX for Advanced Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis

Figure 2

Progression-free survival under FOLFIRI (n = 22, range 1–61 months).